Literature DB >> 31521260

Frequency of Cardiovascular Events and In-hospital Mortality With Opioid Overdose Hospitalizations.

Rajkumar Doshi1, Monil Majmundar2, Tikal Kansara2, Rupak Desai3, Jay Shah4, Ashish Kumar5, Krunalkumar Patel6.   

Abstract

The United States is in the kernel of cataclysmic opioid misuse epidemic with over 33,000 deaths per year from both prescription and illegal opioids use. One of the most common pernicious effects of opioids is on the cardiovascular system. The purpose of this analysis was to determine the incidence of opioid overdose associated cardiovascular events and its impact on short-term outcomes. This was a retrospective, observational study which utilized data from the National Inpatient Sample from January 2005 to September 2015 using International Classifications of Disease, Ninth Revision, Clinical Modification diagnosis codes to identify patients with opioid overdose and associated cardiovascular outcomes. Cardiovascular events were mainly divided into the following 3 parts: Ischemic Events (ischemic stroke and myocardial infarction), acute heart failure, and arrhythmias. The primary outcome of this study was incidence of any cardiovascular event. This study analyzed a total of 430,459 patients hospitalized with opioid overdose, out of which 36,837 (8.6%) had at least 1 cardiovascular event. In all the opioid overdose hospitalizations, 13,979 (3.2%) developed ischemic events, 3,074 (0.7%) developed acute heart failure, and 22,444 (5.2%) developed arrhythmia. Opioid overdose patients with new-onset cardiovascular events had higher odds for in-hospital mortality (odds ratio 4.55; 95% confidence interval 4.11 to 5.04, p <0.001) as compared to patients without cardiovascular events in the multivariable-adjusted model. This study group also demonstrated longer length of stay and higher cost of hospitalization associated with opioid overdose and associated cardiovascular outcome. In conclusion, opioid overdose is associated with higher rates of cardiovascular events, particularly ischemic events and cardiac arrhythmias. These adverse events eventually lead to higher mortality rates and more resource utilization.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31521260     DOI: 10.1016/j.amjcard.2019.07.068

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations.

Authors:  Rajkumar Doshi; Mihir Dave; Monil Majmundar; Ashish Kumar; Devina Adalja; Mariam Shariff; Rupak Desai; Boback Ziaeian; Saraschandra Vallabhajosyula
Journal:  Heart Lung       Date:  2020-12-21       Impact factor: 2.210

2.  Effects of Substance Use Disorder on In-Hospital Outcomes of Young Patients Presenting With a Cardiovascular Event: A Nationwide Analysis.

Authors:  Ahmed Brgdar; John Gharbin; Ayman Elawad; Jin Yi; Jacob Sanchez; Adey Bishaw; Mohamed E Taha; Edmund Essah Ameyaw; Norman Allen; Mehrotra Prafulla
Journal:  Cureus       Date:  2022-03-01

3.  A Peculiar Case of Fentanyl-Induced Cardiomyopathy.

Authors:  Faraz Badar; Aqsa Ashraf; Md R Bhuiyan; Tia Bimal; Asma Iftikhar
Journal:  Cureus       Date:  2022-08-05

4.  Identification of intraoperative management strategies that have a differential effect on patients with reduced left ventricular ejection fraction: a retrospective cohort study.

Authors:  Michael D Maile; Michael R Mathis; Elizabeth S Jewell; Graciela B Mentz; Milo C Engoren
Journal:  BMC Anesthesiol       Date:  2022-09-10       Impact factor: 2.376

Review 5.  A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).

Authors:  Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.